Skip to main content
Journal cover image

9225 Hodgkin lymphoma treatment with ABVD in the US and the EU: neutropenia occurrence and impaired chemotherapy delivery

Publication ,  Conference
Schwenkglenks, M; Pettengell, R; Culakova, E; Lyman, GH
Published in: European Journal of Cancer Supplements
September 2009

Duke Scholars

Published In

European Journal of Cancer Supplements

DOI

ISSN

1359-6349

Publication Date

September 2009

Volume

7

Issue

2

Start / End Page

567 / 567

Publisher

Elsevier BV

Related Subject Headings

  • Oncology & Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Schwenkglenks, M., Pettengell, R., Culakova, E., & Lyman, G. H. (2009). 9225 Hodgkin lymphoma treatment with ABVD in the US and the EU: neutropenia occurrence and impaired chemotherapy delivery. In European Journal of Cancer Supplements (Vol. 7, pp. 567–567). Elsevier BV. https://doi.org/10.1016/s1359-6349(09)71916-0
Schwenkglenks, M., R. Pettengell, E. Culakova, and G. H. Lyman. “9225 Hodgkin lymphoma treatment with ABVD in the US and the EU: neutropenia occurrence and impaired chemotherapy delivery.” In European Journal of Cancer Supplements, 7:567–567. Elsevier BV, 2009. https://doi.org/10.1016/s1359-6349(09)71916-0.
Schwenkglenks M, Pettengell R, Culakova E, Lyman GH. 9225 Hodgkin lymphoma treatment with ABVD in the US and the EU: neutropenia occurrence and impaired chemotherapy delivery. In: European Journal of Cancer Supplements. Elsevier BV; 2009. p. 567–567.
Schwenkglenks, M., et al. “9225 Hodgkin lymphoma treatment with ABVD in the US and the EU: neutropenia occurrence and impaired chemotherapy delivery.” European Journal of Cancer Supplements, vol. 7, no. 2, Elsevier BV, 2009, pp. 567–567. Crossref, doi:10.1016/s1359-6349(09)71916-0.
Schwenkglenks M, Pettengell R, Culakova E, Lyman GH. 9225 Hodgkin lymphoma treatment with ABVD in the US and the EU: neutropenia occurrence and impaired chemotherapy delivery. European Journal of Cancer Supplements. Elsevier BV; 2009. p. 567–567.
Journal cover image

Published In

European Journal of Cancer Supplements

DOI

ISSN

1359-6349

Publication Date

September 2009

Volume

7

Issue

2

Start / End Page

567 / 567

Publisher

Elsevier BV

Related Subject Headings

  • Oncology & Carcinogenesis